🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Edenred shares drop over 13% after Q3 revenue miss, narrowed 2024 guidance

Published 24/10/2024, 08:36 pm
© Reuters.
EDEN
-

Investing.com -- Shares of Edenred (EPA:EDEN) fell sharply on Thursday following the release of its Q3 results, an about 2% miss on revenue expectations and a more cautious outlook for 2025 and 2026. 

At 5:34 am (0934 GMT), Edenred was trading 13.8% lower at €29.65.

The company reported total revenues of €682 million, falling short of the consensus estimate of €695 million. 

Edenred also narrowed its 2024 EBITDA guidance to €1,245–1,285 million, shifting to the middle of its previous range of €1,230–1,300 million.

The shortfall in revenue was driven by weaker performance across key divisions and regions. 

Employee Benefits, one of Edenred's largest segments, reported €398 million in revenue, below consensus estimates of €407 million. 

Mobility Solutions and Complementary Solutions also lagged behind market expectations, with revenue of €152 million and €69 million, respectively. 

Geographically, the miss was most prominent in Europe, which generated €367 million compared to the expected €377 million. 

However, Latin America offered a bright spot, exceeding forecasts with €189 million in revenue, up from the consensus of €186 million.

Analysts at Citi Research flagged that the revenue miss, alongside the guidance narrowing to the midpoint of the range, contrasts with Edenred’s typical pattern of tightening guidance toward the higher end. 

This shift could signal that the company’s growth momentum is slowing, particularly as it faces potential regulatory changes in key markets. 

One major concern raised by Citi is the proposed 5% fee cap on meal vouchers in Italy, which could take effect in the first half of 2025. 

Edenred has voiced its disagreement with the proposal, but if it moves forward, it could result in an estimated €60 million impact on sales for the year.

In 2025, Citi expects the fee cap to weigh on EBITDA growth, with a faster growth rate of over 10% versus its mid-term target of 12%.

As a result of the regulatory uncertainty in Italy and the already moderated growth expectations for EBITDA in 2025 and 2026, Edenred's outlook has been clouded and its stock has been pressured.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.